A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL

NCT03931993 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

BIOLOGICAL: Placebo comparator
BIOLOGICAL: Grass MATA MPL

Sponsor

Allergy Therapeutics

Collaborators

[object Object]
[object Object]